(Reuters) -Scynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a potential allergy-inducing compound ...

The cross-reactivity among cephalosporins and between cephalosporins and ... Beall, GN, Rohr, AS, Adelman, DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med ...

The company said there is potential likelihood that a serious anaphylactic reaction in patients, with known hypersensitivity to beta-lactam or penicillin products, could result from receiving these ...

Risk Statement: The potential cross contamination with a non-antibacterial beta-lactam drug substance could lead to hypersensitivity reactions such as swelling, rash, urticaria and anaphylaxis, a ...

FDA has released Guidance for Industry: Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination.In the guidance, FDA stresses the importance of implementing manufacturing ...

Like penicillin, the non-penicillin beta lactam drugs may be sensitizing agents. Cross-contamination can cause drug-induced hypersensitivity reactions in patients, including life-threatening ...

Scynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a potential allergy-inducing compound, sending the ...

Among patients with methicillin-susceptible Staphylococcus aureus bloodstream infections, the risk of death in 30 days is lower with beta-lactam therapy than with vancomycin, 45 and a higher rate ...

(Reuters) -Scynexis said on Monday it would voluntarily recall its antifungal pill, which it has licensed to GSK, due to risk of cross-contamination with a potential allergy-inducing compound ...